Novo Nordisk raises full-year outlook as Wegovy pill rollout speeds up, GLP-1 momentum continues
An oral version of Wegovy beating forecasts gives Novo a needed lift amid intensifying competition with Eli Lilly.
Read at The Pharma Letter →Full coverage · 5 outlets
- The Pharma Letter · lead
- ReutersNovo hikes outlook again as it speeds up Wegovy pill rollout
- Fierce PharmaNovo catches Wegovy pill tailwind in Q3 as CEO eyes new launch horizons in 2027
- BioPharma DiveNovo gets much-needed lift as Wegovy pill tops Wall Street forecasts
- MiamiheraldNovo hikes outlook again as it speeds up Wegovy pill rollout